{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreicptpswi5xagecju65de6uoj4esbb7t32rnpjdcflblv5uis352pi",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mfpjhzzbq3r2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreifreejicyb5sacnyvabd2b5ftrv4dzgvay5jw2tgz2mitpecw6l7m"
    },
    "mimeType": "image/jpeg",
    "size": 286755
  },
  "path": "/news/2026-02-daily-pill-complex-multi-tablet.html",
  "publishedAt": "2026-02-25T13:40:02.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "HIV & AIDS"
  ],
  "textContent": "A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), could effectively replace more complicated HIV treatment regimens used by people living with HIV who are long-term survivors, according to the results of a new phase 3 clinical trial published in The Lancet.",
  "title": "Single daily pill shows promise as replacement for complex, multi-tablet HIV treatment regimens"
}